Delving into the Latest Updates on Jianer Qingjie Granules with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Infectious DiseasesRespiratory Diseases

Active Indication

Acute upper respiratory infection

Inactive Indication-

Originator Organization

China State Institute of Pharmaceutical Industry

Active Organization

China State Institute of Pharmaceutical Industry

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

Main purpose: To evaluate the safety and tolerability of Jianer Qingjie Granules in the treatment of acute upper respiratory tract infection (wind-heat stagnation syndrome) in children, and to provide a basis for the recommended dose in Phase III; Secondary purpose: To evaluate the effectiveness of Jianer Qingjie Granules in the treatment of acute upper respiratory tract infection (wind-heat stagnation syndrome) in children.

Start Date30 Nov 2023

Sponsor / Collaborator

China State Institute of Pharmaceutical Industry

100 Clinical Results associated with Jianer Qingjie Granules

Login to view more data

100 Translational Medicine associated with Jianer Qingjie Granules

Login to view more data

100 Patents (Medical) associated with Jianer Qingjie Granules

Login to view more data

100 Deals associated with Jianer Qingjie Granules

Login to view more data